Institute of Emergency and Critical Care Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
J Biomed Sci. 2011 May 19;18(1):32. doi: 10.1186/1423-0127-18-32.
Adrenomedullin (ADM) exerts its biological functions through the receptor-mediated enzymatic mechanisms that involve protein kinase A (PKA), or neuronal nitric oxide synthase (nNOS). We previously demonstrated that the receptor-mediated cAMP/PKA pathway involves in ADM-enhanced baroreceptor reflex (BRR) response. It remains unclear whether ADM may enhance BRR response via activation of nNOS-dependent mechanism in the nucleus tractus solitarii (NTS).
Intravenous injection of phenylephrine was administered to evoke the BRR before and at 10, 30, and 60 min after microinjection of the test agents into NTS of Sprague-Dawley rats. Western blotting analysis was used to measure the level and phosphorylation of proteins that involved in BRR-enhancing effects of ADM (0.2 pmol) in NTS. The colocalization of PKA and nNOS was examined by immunohistochemical staining and observed with a laser confocal microscope.
We found that ADM-induced enhancement of BRR response was blunted by microinjection of NPLA or Rp-8-Br-cGMP, a selective inhibitor of nNOS or protein kinase G (PKG) respectively, into NTS. Western blot analysis further revealed that ADM induced an increase in the protein level of PKG-I which could be attenuated by co-microinjection with the ADM receptor antagonist ADM22-52 or NPLA. Moreover, we observed an increase in phosphorylation at Ser1416 of nNOS at 10, 30, and 60 min after intra-NTS administration of ADM. As such, nNOS/PKG signaling may also account for the enhancing effect of ADM on BRR response. Interestingly, biochemical evidence further showed that ADM-induced increase of nNOS phosphorylation was prevented by co-microinjection with Rp-8-Br-cAMP, a PKA inhibitor. The possibility of PKA-dependent nNOS activation was substantiated by immunohistochemical demonstration of co-localization of PKA and nNOS in putative NTS neurons.
The novel finding of this study is that the signal transduction cascade that underlies the enhancement of BRR response by ADM in NTS is composed sequentially of cAMP/PKA and nNOS/PKG pathways.
肾上腺髓质素 (ADM) 通过涉及蛋白激酶 A (PKA) 或神经元型一氧化氮合酶 (nNOS) 的受体介导的酶促机制发挥其生物学功能。我们之前的研究表明,受体介导的 cAMP/PKA 途径参与 ADM 增强的压力感受反射 (BRR) 反应。目前尚不清楚 ADM 是否可以通过激活孤束核 (NTS) 中 nNOS 依赖性机制来增强 BRR 反应。
在 Sprague-Dawley 大鼠 NTS 内注射测试药物后 10、30 和 60 分钟,静脉内注射苯肾上腺素以诱发 BRR。Western blot 分析用于测量 ADM(0.2 pmol)增强 BRR 效应涉及的蛋白质的水平和磷酸化。通过免疫组织化学染色和激光共聚焦显微镜观察来检查 PKA 和 nNOS 的共定位。
我们发现,分别向 NTS 内注射 NPLA 或 Rp-8-Br-cGMP(nNOS 或蛋白激酶 G (PKG) 的选择性抑制剂)可减弱 ADM 诱导的 BRR 反应增强。Western blot 分析进一步表明,ADM 诱导 PKG-I 蛋白水平增加,该增加可被 ADM 受体拮抗剂 ADM22-52 或 NPLA 共注射减弱。此外,我们观察到 ADM 给药后 10、30 和 60 分钟,nNOS 的 Ser1416 磷酸化增加。因此,nNOS/PKG 信号也可能是 ADM 增强 BRR 反应的原因。有趣的是,生化证据进一步表明,PKA 抑制剂 Rp-8-Br-cAMP 共注射可阻止 ADM 诱导的 nNOS 磷酸化增加。PKA 依赖性 nNOS 激活的可能性通过 PKA 和 nNOS 在假定的 NTS 神经元中的共定位的免疫组织化学证明得到证实。
本研究的新发现是,ADM 在 NTS 中增强 BRR 反应的信号转导级联依次由 cAMP/PKA 和 nNOS/PKG 途径组成。